Arcturus Therapeutics (ARCT) PT Raised to $172 at Brookline Capital Markets, Following Clinical Update
Brookline Capital Markets analyst Kumaraguru ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
